DrugPatentWatch Database Preview
Aptapharma Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for APTAPHARMA INC, and what generic and branded alternatives to APTAPHARMA INC drugs are available?
APTAPHARMA INC has one approved drug.
Summary for Aptapharma Inc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Aptapharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aptapharma Inc | IBUPROFEN | ibuprofen | SUSPENSION;ORAL | 210602-001 | Nov 23, 2018 | OTC | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
